Medtronic Operating Cash Flow decreased by 57.0% to $1.09B in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $986.00M to $1.09B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 3.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.75B | $1.29B | $713.00M | $3.28B | $2.06B | $1.08B | $453.00M | $2.04B | $2.46B | $875.00M | $1.07B | $2.07B | $2.78B | $986.00M | $1.03B | $2.50B | $2.53B | $1.09B |
| QoQ Change | — | -26.0% | -44.8% | +360.6% | -37.4% | -47.4% | -58.2% | +351.0% | +20.4% | -64.4% | +22.2% | +93.3% | +34.4% | -64.5% | +4.2% | +143.7% | +1.0% | -57.0% |
| YoY Change | — | — | — | — | +17.9% | -16.2% | -36.5% | -37.8% | +19.6% | -19.2% | +136.0% | +1.1% | +12.9% | +12.7% | -3.9% | +21.2% | -9.0% | +10.3% |